Finch Therapeutics Group, Inc.
USD8.70
+1.20 (+16.00%)
CEO
Mark Smith
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.25
Prev. Close
$7.50
Day Low
$7.25
Day High
$8.70
52W Low
$2.00
52W High
$16.10
Market Cap
$0.01B
Volume
0.01M
| -0.1 |
| 31 Dec 2022 | FY | -539.6% | -13315.4% | -119.8% | -70.4% | 0.55 | 4.84 | -0.2 |
| 31 Dec 2021 | FY | -209.1% | -313.8% | -28.8% | -25.8% | 0.03 | 9.64 | -8.1 |
| 31 Dec 2020 | FY | -329.4% | -508.5% | 41.0% | -23.7% | -0.02 | 9.24 | -26.2 |
| 31 Dec 2019 | FY | 96.9% | -204.4% | 34.9% | -20.0% | -2.40 | 6.64 | -49.6 |
| -0.3 |
| 31 Dec 2023 | Q4 | -1.5% | -106.9% | -13.3% | -4.3% | 1.32 | 6.33 | -0.5 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -9.4% | -4.1% | 1.19 | 6.13 | -0.9 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -24.9% | -10.4% | 1.11 | 3.81 | -0.5 |
| 31 Mar 2023 | Q1 | -1177.6% | -59756.1% | -194.0% | -80.9% | 1.10 | 3.16 | -0.1 |
| 31 Dec 2022 | Q4 | -17500.0% | -329025.0% | -27.5% | -16.2% | 0.55 | 4.84 | -0.2 |
| 30 Sept 2022 | Q3 | -918.1% | -29065.2% | -33.2% | -21.3% | 0.43 | 6.56 | -0.5 |
| 30 Jun 2022 | Q2 | -3756.8% | -6307.8% | -14.3% | -10.0% | 0.35 | 7.28 | -1.5 |
| 31 Mar 2022 | Q1 | -4287.0% | -6936.2% | -13.7% | -12.0% | 0.03 | 7.31 | -2.4 |